Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,853 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease.
Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, Stewart GE, Zeidler M, MacKenzie JM, Ironside JW, Summers DM, Knight RS, Will RG. Heath CA, et al. Among authors: murray k. Ann Neurol. 2010 Jun;67(6):761-70. doi: 10.1002/ana.21987. Ann Neurol. 2010. PMID: 20517937
Risk factors for sporadic Creutzfeldt-Jakob disease.
Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, Knight RS, Smith PG, Will RG. Ward HJ, et al. Among authors: murray k. Ann Neurol. 2008 Mar;63(3):347-54. doi: 10.1002/ana.21294. Ann Neurol. 2008. PMID: 18074392
Outcome after conservative management or intervention for unruptured brain arteriovenous malformations.
Al-Shahi Salman R, White PM, Counsell CE, du Plessis J, van Beijnum J, Josephson CB, Wilkinson T, Wedderburn CJ, Chandy Z, St George EJ, Sellar RJ, Warlow CP; Scottish Audit of Intracranial Vascular Malformations Collaborators. Al-Shahi Salman R, et al. JAMA. 2014 Apr 23-30;311(16):1661-9. doi: 10.1001/jama.2014.3200. JAMA. 2014. PMID: 24756516 Free article.
Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.
Tamborska AA, Singh B, Leonhard SE, Hodel EM, Stowe J, Watson-Fargie T, Fernandes PM, Themistocleous AC, Roelofs J, Brennan K, Morrice C, Michael BD, Jacobs BC, McDonald H, Solomon T; UK Covid Vaccine GBS Study Group. Tamborska AA, et al. BMJ Neurol Open. 2022 Jul 12;4(2):e000309. doi: 10.1136/bmjno-2022-000309. eCollection 2022. BMJ Neurol Open. 2022. PMID: 35856053 Free PMC article.
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, Marignier R, McGuigan C, Murray K, Nakashima I, Pandit L, Paul F, Pittock S, Selmaj K, de Sèze J, Siva A, Tanasescu R, Vukusic S, Wingerchuk D, Wren D, Leite I, Palace J. Juryńczyk M, et al. Among authors: murray k. J Neurol. 2016 Jan;263(1):140-9. doi: 10.1007/s00415-015-7952-8. Epub 2015 Nov 3. J Neurol. 2016. PMID: 26530512 Free PMC article.
Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance.
Rashid W, Ciccarelli O, Leary SM, Arun T, Doshi A, Evangelou N, Ford HL, Hobart J, Jacob S, Muraro PA, Murray K, Palace J, Dobson R; Association Of British Neurologists Multiple Sclerosis and Neuroinflammation Advisory Group. Rashid W, et al. Among authors: murray k. Pract Neurol. 2024 Nov 11:pn-2024-004228. doi: 10.1136/pn-2024-004228. Online ahead of print. Pract Neurol. 2024. PMID: 39532459 Review.
2,853 results